Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 196.87M | 4.14 | $ 47.55M |
3/31/2025 | $ 237.18M | 5.65 | $ 42M |
12/31/2024 | $ 276.13M | 6.01 | $ 45.95M |
9/30/2024 | $ 295.1M | 9 | $ 32.79M |
6/30/2024 | $ 278.97M | 8.15 | $ 34.22M |
3/31/2024 | $ 196.76M | 7.47 | $ 26.34M |
12/31/2023 | $ 169.19M | 5.42 | $ 31.21M |
9/30/2023 | $ 182.12M | 7.06 | $ 25.79M |
6/30/2023 | $ 81.33M | 3.04 | $ 26.77M |
3/31/2023 | $ 95.97M | 3.8 | $ 25.23M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for UROGEN PHARMA LTD is calculated as follows: AssetsC [ $ 129.34M ] / LiabilitesC [ $ 17.62M ]
(=) Current Ratio [ 7.34 ]
Minimum
Jun 30, 2023
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |